Drug Research
BioGenes, Alphalyse partner to optimize ELISA reagent characterization for biomanufacturing
BioGenes has partnered with Alphalyse, a specialist contract research organization. Recently, two companies that have been active in the field of Host Cell Protein (HCP)...
Drug Research
Berkshire Sterile to offer formulation, lyophilization, and method development services
Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has recently added formulation, lyophilization, and method development capabilities to complement their...
Drug Research
Seqirus Announces New Facility Supporting Research & Development of Leading-Edge Influenza Vaccine Technology
Seqirus, a global leader in influenza prevention and a business of CSL Limited announced an investment in a new Research and Development (R&D) facility located...
Drug Research
Piramal Pharma Solutions Strengthens UK Presence with the Expansion and Upgrade of its Grangemouth and Morpeth Facilities
Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the...
Drug Research
DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development
DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead...
Drug Research
Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies
Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva...
Drug Research
Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody
Biogen Inc. announced that it exercised its option to participate in the development and commercialization of mosunetuzumab. Biogen will pay a $30 million one-time option...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.